NP / PA
Dixon, Lutdavone
Dixon, Lutdavone was paid $194K by Medicaid between Oct 2020 and Nov 2024, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 64% of everything it billed.
33Billing provider infoDIXON, LUTDAVONE
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1295361665assigned 03/18/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$194K
24GClaims4,180
24DCodes billed11
24AFirst – last monthOct 2020 – Nov 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Rhode Island
Rank by total paid#33 of 266
Median peer was paid$31K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 110 | $4K | |
| 2021 | 668 | $31K | |
| 2022 | 1,590 | $74K | |
| 2023 | 750 | $33K | |
| 2024incomplete | 1,062 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 64% | 2,677 | 2,587 | $123K |
| 87428 | 15% | 518 | 508 | $29K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 12% | 278 | 265 | $23K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.7% | 96 | 84 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 439 | 430 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 15 | 14 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 15 | 14 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 71 | 71 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 29 | 28 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 30 | 29 | $466.99 |
| 87070 | <1% | 12 | 12 | $237.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.